{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T19:33:46Z","timestamp":1784662426830,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["7042024"],"award-info":[{"award-number":["7042024"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["7081002"],"award-info":[{"award-number":["7081002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2003-2037"],"award-info":[{"award-number":["2003-2037"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.clinthera.2010.04.008","type":"journal-article","created":{"date-parts":[[2010,4,30]],"date-time":"2010-04-30T04:57:25Z","timestamp":1272603445000},"page":"692-700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Three-week combination treatment with ACTH + magnesium sulfate versus ACTH monotherapy for infantile spasms: A 24-week, randomized, open-label, follow-up study in China"],"prefix":"10.1016","volume":"32","author":[{"given":"Li-Ping","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Hong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruo-Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2010.04.008_bib1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/088307389100600412","article-title":"The epidemiology and natural history of infantile spasms","volume":"6","author":"Cowan","year":"1991","journal-title":"J Child Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2010.04.008_bib2","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/j.eplepsyres.2006.01.017","article-title":"The influence of etiology upon ictal semiology, treatment decisions and long-term outcomes in infantile spasms and West syndrome","volume":"70","author":"Lux","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.clinthera.2010.04.008_bib3","first-page":"477","article-title":"Glutamate, GABA and epilepsy","volume":"47","author":"Bradford","year":"1995","journal-title":"ProgNeurobiol"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2010.04.008_bib4","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.expneurol.2004.03.027","article-title":"Development of neurotransmitter systems during critical periods","volume":"190","author":"Herlenius","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1016\/j.clinthera.2010.04.008_bib5","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1528-1157.1999.tb02006.x","article-title":"Age-specific N-methyl -D-aspartate-induced seizures: Perspectives for the West syndrome model","volume":"40","author":"K\u00e1bov\u00e1","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinthera.2010.04.008_bib6","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1212\/01.WNL.0000127773.72699.C8","article-title":"Practice parameter: Medical treatment of infantile spasms: Report of the American Academy of Neurology and the Child Neurology Society","volume":"62","author":"Mackay","year":"2004","journal-title":"Neurolog"},{"key":"10.1016\/j.clinthera.2010.04.008_bib7","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/adc.55.9.664","article-title":"ACTH therapy in infantile spasms: Side effects","volume":"55","author":"Riikonen","year":"1980","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.clinthera.2010.04.008_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00004728-198002000-00004","article-title":"Cerebral atrophy following ACTH therapy","volume":"4","author":"Okuno","year":"1980","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.clinthera.2010.04.008_bib9","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1528-1157.1997.tb00063.x","article-title":"Vigabatrin versus ACTH as first-line treatment for infantile spasms: A randomized, prospective study","volume":"38","author":"Vigevano","year":"1997","journal-title":"Epilepsia"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2010.04.008_bib10","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1111\/j.1528-1157.2000.tb02180.x","article-title":"Long-term response to topiramate in patients with West syndrome","volume":"41","author":"Glauser","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinthera.2010.04.008_bib11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/WNF.0b013e3180986d43","article-title":"Evaluation of open-label topiramate as primary or adjunctive therapy in infantile spasms","volume":"31","author":"Zou","year":"2008","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.clinthera.2010.04.008_bib12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/01.WNF.0000236768.54150.8C","article-title":"Prospective study of first-choice topiramate therapy in newly diagnosed infantile spasms","volume":"29","author":"Zou","year":"2006","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.clinthera.2010.04.008_bib13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00004691-200311000-00004","article-title":"Infantile epileptic encephalopathy with hypsarrhythmia (infantile spasms\/West syndrome)","volume":"20","author":"Hrachovy","year":"2003","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.clinthera.2010.04.008_bib14","first-page":"813","article-title":"A risk-benefit assessment of treatments for infantile spasms","volume":"24","author":"Nabbout","year":"2001","journal-title":"DrugSaf"},{"key":"10.1016\/j.clinthera.2010.04.008_bib15","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1517\/14656566.4.11.2039","article-title":"Infantile spasms","volume":"4","author":"Zupanc","year":"2003","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.clinthera.2010.04.008_bib16","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/0002-9378(92)91749-Z","article-title":"Peripheral magnesium sulfate enters the brain and increases the threshold for hippocampal seizures in rats","volume":"167","author":"Hallak","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clinthera.2010.04.008_bib17","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ajog.2009.04.004","article-title":"Magnesium sulfate for the prevention of cerebral palsy","volume":"200","author":"Rouse","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clinthera.2010.04.008_bib18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.brainres.2006.01.024","article-title":"Early developmental alterations of low-Mg2+-induced epileptiform activity in the intact corticohippocampal formation of the newborn mouse in vitro","volume":"1077","author":"Moser","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.clinthera.2010.04.008_bib19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Proposal for revised classification of epilepsies and epileptic syndromes","volume":"30","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinthera.2010.04.008_bib20","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1651-2227.2002.tb00102.x","article-title":"Effects of magnesium sulphate on amplitude integrated continuous EEG in asphyxiated term neonates","volume":"91","author":"Groenendaal","year":"2002","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.clinthera.2010.04.008_bib21","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1212\/WNL.39.8.1027","article-title":"Treatment of infantile spasms with high-dose ACTH: Efficacy and plasma levels of ACTH and cortisol","volume":"39","author":"Snead","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2010.04.008_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-3806(03)00005-1","article-title":"Effect of recurrent epileptiform discharges induced by magnesium-free treatment on developing cortical neurons in vitro","volume":"142","author":"Cao","year":"2003","journal-title":"Brain Res Dev Brain Res"},{"key":"10.1016\/j.clinthera.2010.04.008_bib23","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1001\/jama.290.20.2669","article-title":"Effect of magnesium sulfate given for neuroprotection before preterm birth: A randomized controlled trial","volume":"290","author":"Crowther","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2010.04.008_bib24","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1113\/expphysiol.2007.039966","article-title":"Magnesium sulphate treatment decreases blood-brain barrier permeability during acute hypertension in pregnant rats","volume":"93","author":"Euser","year":"2008","journal-title":"Exp Physiol"},{"key":"10.1016\/j.clinthera.2010.04.008_bib25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/1933719107305864","article-title":"Neuroprotective effect of long-term MgSO4 administration after cerebral hypoxia-ischemia in newborn rats is related to the severity of brain damage","volume":"14","author":"Spandou","year":"2007","journal-title":"Reprod Sci"},{"key":"10.1016\/j.clinthera.2010.04.008_bib26","first-page":"1129","article-title":"MgSO4 treatment preserves the ischemia-induced reduction in S-100 protein without modification of the expression of endothelial tight junction molecules","volume":"24","author":"Go\u00f1i-de-Cerio","year":"2009","journal-title":"Histol Histopathol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291810001323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291810001323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:49:09Z","timestamp":1778669349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291810001323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0149291810001323"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2010.04.008","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Three-week combination treatment with ACTH + magnesium sulfate versus ACTH monotherapy for infantile spasms: A 24-week, randomized, open-label, follow-up study in China","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2010.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Excerpta Medica Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}